Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 12 of 12 for “"B-cell activating factor (BAFF)"”.
-
Impact of B cell Activating Factor (BAFF) on Autoimmune Neuroinflammation
… disease, is mediated by myelin-reactive CD4+ T cells. Anti-CD20 B cell depletion therapies are highly effective at treating MS, but the mechanisms underpinning this protection are poorly defined. Paradoxically, removal of B lineage cells by targeting B cell survival factors, including the B cell …
-
Novel mechanisms involving B cell receptor (BCR) and B cell activating factor (BAFF) signaling pathways underlying human primary immunodeficiencies and malignancy
… and survival of human peripheral immature B cells relies on two critical signaling pathways: B cell receptor (BCR) signaling and the B cell activating factor (BAFF)/BAFF-receptor (BAFF-R) signaling axis. The quality of the BCR signal is regulated in a developmental manner. Self-reactive early …
-
Συμμετοχή του παράγοντα ενεργοποίησης Β-κυττάρων (B-cell activating factor-BAFF) στη σχετική με τη ρευματοειδή αρθρίτιδα και το σύνδρομο Sjogren Αθηροσκλήρωση
… pathogenetic mechanism. Even if traditional risk factors, such as hypertension, diabetes mellitus, hyperlipidemia, smoking, obesity and physical inactivity are found more frequently in the patient group, this imbalance does not seem to substantially explain mortality rate differences. Large cohort …
-
Ο ρόλος του γονιδίου και της πρωτεΐνης TACI σε ασθενείς με σαρκοείδωση
… is presumed to be dictated by enhanced T cell immunity deregulation, however studies have suggested that patients with sarcoidosis exhibit an augmented humoral immune response manifested by increased amount of circulating immunoglobulins and the presence of autoantibodies. However the …
-
INVESTIGATING B CELLS IN COMPARTMENTALIZED AND PERIPHERAL INFLAMMATION DURING CENTRAL NERVOUS SYSTEM AUTOIMMUNITY
… of the brain and spinal cord whereby immune cells collaborate to mediate demyelination. B cell depleting therapies (anti-CD20) are used to treat both MS and MOGAD, though it remains unknown whether treatment success can be attributed to targeting of peripheral B cells or those localized to …
-
Η ιντερλευκίνη-17Α και ο ενεργοποιητικός παράγοντας των Β λεμφοκυττάρων σε ασθενείς με χρόνια ηπατίτιδα C και μικτή κρυοσφαιριναιμία: επιδράσεις της αντιιικής θεραπείας και συσχετίσεις με τη βιταμίνη D
… mixed cryoglobulinemia (MC). The importance of B-cell activating factor (BAFF) in MC has been described, but the role of interleukin (IL)-17A is less clear. Aim of the Study: The main objectives were to determine the levels of BAFF and IL-17A cytokines in patients with CHC with or without MC, and …
-
Brain-reactive antibodies in inflammatory and degenerative diseases of the central nervous system (CNS)
… anti-cluster of differentiation 20 (CD20) cell depletion therapy, ocrelizumab, beyond its effect on B-cell depletion. We propose that, in addition to targeting CD20-positive B cells, the elimination of CD20-positive T cells and changes in the levels of B-cell regulatory factors also play a …
-
B CELL ACTIVATING FACTOR AND MATRIX METALLOPROTEINASE-2 AS NOVEL MODULATORS OF INSULIN RESISTANCE AND GLUCOSE UTILIZATION
… tissue mediated by the infiltration of immune cells. In recent years, many studies have highlighted the importance of understanding the interplay between the body's metabolic state and the activation of the immune system in type 2 diabetes. Here, we identify novel roles for B cell-activating …
-
Μελέτη της σύστασης και της λειτουργίας της λιποπρωτεΐνης υψηλής πυκνότητας (HDL) σε παθολογικές καταστάσεις, καθώς και της ενίσχυσης των αθηροπροστατευτικών λειτουργιών της HDL με μικρά μόρια
… Belimumab is a monoclonal antibody against B-cell activating factor (BAFF), implicated in disease progression and associated with subclinical atherosclerosis. The analyses showed that belimumab treatment may improve the HDL atheroprotective properties and modify the HDL lipidomic signature in …
-
Molecular and immunological mechanisms of B cell activating factor-driven B cell dysregulation in CVID
… with profound pulmonary infiltration of T and B cells, granulomatous inflammation, and dysregulated B cell activation, suggesting that intrinsic immune abnormalities contribute to its development. B cell depletion therapy ameliorates disease in a subset of CVID ILD, yet variability in treatment …
-
INVESTIGATING THE IMMUNOBIOLOGY OF IgE+ B CELLS AND REGULATORY B CELLS IN ALLERGIC ASTHMA
… (-eg- histamine) released by granulocytic cells (-eg- mast cells and basophils). However, immunoglobulin E (IgE) antibody is also necessary for the initiation of the allergic cascade, and IgE is produced and released exclusively by memory B cells and plasma cells. Allergen crosslinking of …
-
Local and systemic effects of adipocyte-secreted factors in breast cancer
… progresses in response to multiple environmental factors, including local microenvironmental factors within the breast and systemic markers in circulation. Obesity affects one third of all New Zealand adults and is known to negatively impact breast cancer outcomes. Epidemiological studies have …